[177Lu]Lu‐PSMA‐617 Plus Short‐Course Priming With Enzalutamide in Metastatic Castration‐Resistant Prostate Cancer: A Single‐Arm Phase 2 Trial (Lu‐PRIME)
Piyush Aggarwal, Ashwani Sood, Swayamjeet Satapathy, Shikha Goyal, Komalpreet Kaur, Gaurav Prakash et al. [177Lu]Lu‐PSMA‐617 Plus Short‐Course Priming With Enzalutamide in Metastatic Castration‐Resistant Prostate Cancer: A Single‐Arm Phase 2 Trial (Lu‐PRIME). // Prostate. – 2026. – DOI: 10.1002/pros.70253. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pros.70253?af=R
Piyush Aggarwal, Ashwani Sood, Swayamjeet Satapathy, Shikha Goyal, Komalpreet Kaur, Gaurav Prakash, Kannan Periasamy, & Bhagwant Rai Mittal (2026). [177Lu]Lu‐PSMA‐617 Plus Short‐Course Priming With Enzalutamide in Metastatic Castration‐Resistant Prostate Cancer: A Single‐Arm Phase 2 Trial (Lu‐PRIME). Prostate. https://doi.org/10.1002/pros.70253
Piyush Aggarwal, et al. “[177Lu]Lu‐PSMA‐617 Plus Short‐Course Priming With Enzalutamide in Metastatic Castration‐Resistant Prostate Cancer: A Single‐Arm Phase 2 Trial (Lu‐PRIME).” Prostate, 2026. doi:10.1002/pros.70253.
@article{Aggarwal2026,
title = {[177Lu]Lu‐PSMA‐617 Plus Short‐Course Priming With Enzalutamide in Metastatic Castration‐Resistant Prostate Cancer: A Single‐Arm Phase 2 Trial (Lu‐PRIME)},
author = {Aggarwal, Piyush and Sood, Ashwani and Satapathy, Swayamjeet and Goyal, Shikha and Kaur, Komalpreet and Prakash, Gaurav and Periasamy, Kannan and Mittal, Bhagwant Rai},
journal = {Prostate},
year = {2026},
doi = {10.1002/pros.70253},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pros.70253?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...